Clinical Trial

MAPS PrEP Van Study

Study acronym: MAPS PrEP
Completed Phase 4
View on ClinicalTrials.gov →
Summary
For this study the investigators aim to see if giving participants an oral HIV prevention medication on a medical van, is a good option of care for individuals who inject drugs and/or are sexually active and therefore at a higher risk of contracting HIV.
Protocol Amendment History 4 changes
critical Trial completed 2026-07-25
notable Enrollment reduced: 20 -> 7 participants 2026-07-25
notable Primary completion moved earlier: 2026-06-30 -> 2026-05-13 2026-07-25
minor Completion moved earlier: 2026-07-31 -> 2026-05-13 2026-07-25
Trial Details
NCT Number NCT06908252
Lead Sponsor Duke University
Collaborators: National Institute of Allergy and Infectious Diseases (NIAID)
Conditions HIV Infection
Enrollment 7 participants
Start Date 2025-09-17
Primary Completion 2026-05-13 (estimated)
Study Completion 2026-05-13 (estimated)
Updated on ClinicalTrials.gov 2026-07-24